Peter Jorth

20PUBLICATIONS
39CO-AUTHORS
BacteriologySpeciation and extinctionEnvironmental epidemiologyInfant and child healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 25, 2026
Challenges in establishing epidemiological cut-off values for the Burkholderia cepacia complex.

|Sep 25, 2025
Evolutionary loss of an antibiotic efflux pump increases Pseudomonas aeruginosa quorum sensing mediated virulence in vivo.

Sheryl E Fernandes, Humberto Ortega, Mylene Vaillancourt

|Jun 27, 2025
ESBL-Producing Escherichia coli and Klebsiella pneumoniae Exhibit Divergent Paths During In-Human Evolution Towards Carbapenem Resistance.

Michelle Chioma Kalu, Akanksha Acharya, Peter Jorth

|Jun 20, 2025
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study.

Jessica E Pittman, Sarah Morgan, Morgan McCreary

|Jun 13, 2025
A chronic Pseudomonas aeruginosa mouse lung infection modeling the mucus obstruction, lung function, and inflammation of human cystic fibrosis.

Mylene Vaillancourt, Sheryl E Fernandes, Diane Aguilar

|Jan 22, 2025
Evaluation of antimicrobial susceptibility testing methods for Burkholderia cepacia complex isolates from people with and without cystic fibrosis.

Peter Jorth, Carmila Manuel, Tracey McLemore

Pageof 4

Frequent Collaborators

3 joint publications

John J LiPuma

2 joint publications

Michelle Kalu

2 joint publications

Elizabeth B Burgener

2 joint publications

Sheryl E Fernandes